TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
IrenePharma Oy
Closing information (x1000 EUR)
| Closing information | 2017/10 | 2016/10 | 2015/10 |
| Turnover |
1,943
|
1,745
|
1,520 |
| Financial expenses |
2
|
2
|
0 |
| Earnings before taxes |
425
|
356
|
308 |
| Total assets |
1,313
|
1,110
|
881 |
| Current assets |
27
|
14
|
173 |
| Current liabilities |
103
|
90
|
82 |
| Equity capital |
1,211
|
1,020
|
799 |
| - share capital |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2017/10 | 2016/10 | 2015/10 |
| Solvency |
92.2%
|
91.9%
|
90.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
21.9%
|
20.4%
|
20.3% |
| Return on assets (ROA) |
32.5%
|
32.3%
|
35.0% |
| Current ratio |
26.2%
|
15.6%
|
211.0% |
| Return on equity (ROE) |
35.1%
|
34.9%
|
38.5% |
| Change turnover |
198
|
225
|
37 |
| Change turnover % |
11%
|
15%
|
2% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2017/10 | 2016/10 | 2015/10 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.